ONCODNA

In News

IntegraGen: Sales of €2.5 Million in the First Half of 2025 and Cash Position of €2.1 Million - Business Wire

Business Wire - Jul 02, 2025

Precision Oncology Company OncoDNA Closes $20M Series B Financing - Inside Precision Medicine

Inside Precision Medicine - Feb 14, 2020

SYNLAB partners with OncoDNA to provide comprehensive biomarker testing for cancer therapy selection in Germany - SYNLAB

SYNLAB - Mar 29, 2022

World Cancer Day: Advancing Precision Cancer Care - News-Medical

News-Medical - Feb 04, 2025

Osborne Clarke advises OncoDNA on its successful Round C financing - Osborne Clarke

Osborne Clarke - Jul 05, 2023

Bridging the Gap Between Biomarker Testing and Treatment in Community Oncology - The American Journal of Managed Care

The American Journal of Managed Care - Dec 02, 2025

Converge Biotech announces collaboration With OncoDNA to personalise cancer care in India - expresshealthcare.in

expresshealthcare.in - Feb 10, 2021

Osborne Clarke advised OncoDNA on their friendly takeover bid of IntegraGen - Osborne Clarke

Osborne Clarke - Jul 09, 2020

PDC*line Pharma, partners get €8.1mn from Walloon region, BioWin for personalised therapeutic vaccine - Express Pharma

Express Pharma - Jan 18, 2024

Converge Biotech: Embracing The Advancement Of Healthcare Products And The Technologies To Ensure Better Treatment Outcomes - Asia Business Outlook

Asia Business Outlook - Nov 13, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment